Sugi Predict

Sugi Predict / Compounds / SCHEMBL3099849

SCHEMBL3099849

SCHEMBL3099849

O=C(O)C1CCC(O)C(O)C1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACE P12821 1/20 0.43
▸ AKR1C3 P42330 1/20 0.42
▸ AKR1C1 Q04828 1/20 0.42
▸ GABRR1 P24046 1/20 0.42
▸ PLG P00747 1/20 0.39
▸ PLAT P00750 1/20 0.39
▸ LMNA P02545 1/20 0.39
▸ GABRP O00591 1/20 0.39
▸ GABRD O14764 1/20 0.39
▸ GABRA1 P14867 1/20 0.39
▸ TSHR P16473 1/20 0.39
▸ GABRB1 P18505 1/20 0.39
▸ GABRG2 P18507 1/20 0.39
▸ GABRB3 P28472 1/20 0.39
▸ GABRA5 P31644 1/20 0.39
▸ GABRA3 P34903 1/20 0.39
▸ GABRA2 P47869 1/20 0.39
▸ GABRB2 P47870 1/20 0.39
▸ GABRA4 P48169 1/20 0.39
▸ GABRE P78334 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2182894 1.00 ACE (0.43) ACEAKR1C3AKR1C1GABRR1PLG
SCHEMBL4416794 1.00 ACE (0.43) ACEAKR1C3AKR1C1GABRR1PLG
SCHEMBL30839239 1.00 ACE (0.43) ACEAKR1C3AKR1C1GABRR1PLG
SCHEMBL1345147 1.00 ACE (0.43) ACEAKR1C3AKR1C1GABRR1PLG
SCHEMBL16392460 1.00 ACE (0.43) ACEAKR1C3AKR1C1GABRR1PLG
SCHEMBL2184867 1.00 ACE (0.43) ACEAKR1C3AKR1C1GABRR1PLG
SCHEMBL2184629 1.00 ACE (0.43) ACEAKR1C3AKR1C1GABRR1PLG
SCHEMBL1344569 1.00 ACE (0.43) ACEAKR1C3AKR1C1GABRR1PLG
SCHEMBL2932019 1.00 ACE (0.43) ACEAKR1C3AKR1C1GABRR1PLG
SCHEMBL11155834 0.84 GABRR1 (0.48) ACEAKR1C3AKR1C1GABRR1PLG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 67 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210253540-A1 REDOX-ACTIVE COMPOUNDS AND USES THEREOF CMBLU PROJEKT AG (DE) 2021-08-19 — — US claimed
CN-113166079-A Redox active compounds and their use 克姆布鲁项目公司 2021-07-23 — — CN claimed
EP-3837246-A2 REDOX-ACTIVE COMPOUNDS AND USES THEREOF CMBlu Projekt AG (DE) 2021-06-23 — — EP claimed
WO-2020035548-A2 REDOX-ACTIVE COMPOUNDS AND USES THEREOF CMBLU PROJEKT AG (DE) 2020-02-20 — — WO claimed
EP-3169166-A1 CYCLOHEXANECARBOXYLIC ACIDS FOR SELECTIVE TASTE MASKING International Flavors & Fragrances Inc. (US) 2017-05-24 — — EP claimed
WO-2016209664-A1 CYCLOHEXANECARBOXYLIC ACIDS FOR SELECTIVE TASTE MASKING INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) 2016-12-29 — — WO claimed
US-20250263384-A9 REDOX-ACTIVE COMPOUNDS AND USES THEREOF CMBLU ENERGY AG (DE) 2025-08-21 — — US disclosed
US-20240124405-A1 REDOX-ACTIVE COMPOUNDS AND USES THEREOF CMBLU PROJECKT AG (DE) 2024-04-18 — — US disclosed
CN-116769648-A Fermentation medium and method for producing rapamycin through fermentation 丽珠集团福州福兴医药有限公司 2023-09-19 — — CN disclosed
US-11731945-B2 Redox-active compounds and uses thereof CMBLU ENERGY AG (DE) 2023-08-22 — — US disclosed
US-11731945-B2 Redox-active compounds and uses thereof CMBLU ENERGY AG (DE) 2023-08-22 — — US disclosed
US-11731945-B2 Redox-active compounds and uses thereof CMBLU ENERGY AG (DE) 2023-08-22 — — US disclosed
CN-106793810-B Cyclohexane carboxylic acids for selective taste masking 国际香料和香精公司 2021-08-20 — — CN disclosed
WO-2001068867-A1 POLYKETIDES AND THEIR SYNTHESIS BIOTICA TECHNOLOGY LIMITED (GB) 2001-09-20 — — WO disclosed
EP-1091971-A2 POLYKETIDES AND THEIR SYNTHESIS Biotica Technology Limited (GB) 2001-04-18 — — EP disclosed
WO-2000071557-A1 13-METHYL-ERYTHROMYCIN DERIVATIVES PFIZER PRODUCTS INC. (US) 2000-11-30 — — WO disclosed
US-6063561-A ERYTHROMYCIN DERIVATIVES IN WHICH METHYL GROUPS ON THE MACROLACTONE RING ARE SUBSTITUTED WITH HYDROGEN, ETHYL AND/OR HYDROXY GROUPS AND THE ETHYL SIDE-CHAIN HAS BEEN SUBSTITUTED WITH HYDROXYMETHYL OR DIHYDROXYCYCLOHEXYLMETHYL SIDE-CHAINS ABBOTT LABORATORIES (US) 2000-05-16 — — US disclosed
WO-2000000500-A2 POLYKETIDES AND THEIR SYNTHESIS BIOTICA TECHNOLOGY LIMITED (GB) 2000-01-06 — — WO disclosed
EP-0956288-A2 NOVEL POLYKETIDE DERIVATIVES AND RECOMBINANT METHODS FOR MAKING SAME Abbott Laboratories (US) 1999-11-17 — — EP disclosed
WO-1998051695-A2 NOVEL POLYKETIDE DERIVATIVES AND RECOMBINANT METHODS FOR MAKING SAME ABBOTT LABORATORIES (US) 1998-11-19 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240124405-A1 REDOX-ACTIVE COMPOUNDS AND USES THEREOF NOX4, NQO1, GPX1 ACE 469/4885AKR1C3 495/4885AKR1C1 416/4885
US-20250263384-A9 REDOX-ACTIVE COMPOUNDS AND USES THEREOF NOX4, NQO1, GPX1 ACE 469/4885AKR1C3 495/4885AKR1C1 416/4885
US-11731945-B2 Redox-active compounds and uses thereof NOX4, NQO1, GPX1 ACE 469/4885AKR1C3 495/4885AKR1C1 416/4885
US-20210253540-A1 REDOX-ACTIVE COMPOUNDS AND USES THEREOF NOX4, NQO1, GPX1 ACE 469/4885AKR1C3 495/4885AKR1C1 416/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.